RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. Capital expenditures

BOSTON SCIENTIFIC CORPBSX

Market cap
$145B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-790+11.11%
Dec 31, 2023-711+20.92%
Dec 31, 2022-588+6.14%
Dec 31, 2021-554+47.34%
Dec 31, 2020-376-18.44%
Dec 31, 2019-461+45.89%
Dec 31, 2018-316-0.94%
Dec 31, 2017-319-15.16%
Dec 31, 2016-376+52.23%
Dec 31, 2015-247-4.63%
Dec 31, 2014-259+5.71%
Dec 31, 2013-245+8.41%
Dec 31, 2012-226-25.66%
Dec 31, 2011-304+11.76%
Dec 31, 2010-272

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)